A recent study tracking the leukemia cells of AML patients before and after chemotherapy found that CD34+CD38- LSCs and AML blasts were equally eliminated, and LSCs no longer remained quiescent after chemotherapy (21, 63). The gene discussed is CD38; the disease is acute myeloid leukemia.